Introduction
In eukaryotic cells, microtubules (MTs) are nucleated from the primary MT organizing centre (MTOC) which, in higher organisms, is the centrosome and, in unicellular fungi, is the spindle pole body (SPB) (Doxsey, 2001; Francis and Davis, 2000; Hagan and Petersen, 2000) . Centrosomes, about 1 mm in diameter, are complex structures consisting of two centrioles surrounded by an extended meshwork of pericentriolar material (PCM). Centrioles are composed of nine short triplets of heavily modified MTs organized into a barrel, to which PCM proteins are attached through protein-protein interactions. The structure and function of the centrosome is carefully regulated through the cell cycle (Hinchcliffe and Sluder, 2001) . In interphase, the centrosome nucleates long, relatively stable MTs that are responsible for determining cell shape, motility and the intracellular positioning of subcellular organelles. In mitosis, the centrosomes form the two poles of the mitotic spindle and contribute to nucleation and organization of the highly dynamic spindle MTs. As each spindle pole contains two centrioles, the centrosome must undergo a duplication event to create four centrioles by the time cells enter mitosis. Centrosome duplication is temporally coordinated with DNA replication so that each process occurs only once per cell cycle.
Genetic, biochemical and cell biology studies have revealed a number of protein kinases and phosphatases that localize to the centrosome and, in some way, regulate its structure and activity (Brinkley and Goepfert, 1998; Fry et al., 2000a; Whitehead and Salisbury, 1999) . Most of these exhibit cell cycledependent activity emphasizing the requirement for phosphorylation in controlling the centrosome cycle. The most well characterized centrosome kinases are cyclin-dependent kinases 1 and 2 (CDK1 and CDK2), Polo kinases and Aurora kinases, particularly Aurora-A (Nigg, 2001) . However, another family of protein kinases is now emerging as a major regulator of the centrosome: the NIMA-related kinases. NIMA was first identified in the filamentous fungus Aspergillus nidulans as a protein whose kinase activity is essential for mitotic entry (Fry and Nigg, 1995; Osmani and Ye, 1996) . Temperature-sensitive nimA mutants arrest in G2 at the restrictive temperature, while overexpression of NIMA leads to a rapid entry into mitosis from any point in the cell cycle. This is characterized by premature nuclear envelope breakdown, chromatin condensation and mitotic spindle formation. The closest relative of NIMA in human cells is Nek2, and a body of evidence is now accumulating that Nek2 also plays a vital role in cell cycle progression, particularly with respect to the centrosome cycle.
Nek2: a NIMA-related kinase
In mammals, seven NIMA-related kinases, or Neks, have been reported, although they tend only to be conserved within their catalytic domains (Holland et al., 2002; Kandli et al., 2000; Letwin et al., 1992; Levedakou et al., 1994; Schultz et al., 1994; Schultz and Nigg, 1993; Tanaka and Nigg, 1999) . Nek2 is the most closely related kinase in the human genome to NIMA, being 44% identical in amino acid sequence across the catalytic domain. For this reason, it has become the best studied of the vertebrate NIMArelated kinases, and little is known about the function of the others. Nek1, the first mammalian NIMArelated kinase to be identified, has serendipitously been found to be the gene mutated in a laboratory strain of mouse that suffers from severe developmental defects (Upadhya et al., 2000) . Meanwhile, Nek6 and Nek7 were purified as upstream kinases of the p70 ribosomal S6 kinase, although the in vivo relevance of this activity has yet to be determined (Belham et al., 2001) .
Vertebrate Nek2 proteins have so far been studied in human, mouse, pig and the African clawed toad, Xenopus laevis. However, proteins that are structurally related to Nek2 also exist in the fruitfly Drosophila melanogaster (C Sunkel, personal communication), the slime mould Dictyostelium discoideum (Graf, 2002) , and other unicellular fungi (Table 1 ). The most closely related proteins to either Nek2 or NIMA in budding and fission yeast are KIN3 and Fin1p, respectively (Barton et al., 1992; Jones and Rosamond, 1990; Krien et al., 1998; Schweitzer and Philippsen, 1992) . These share about as much similarity with Nek2 as they do with NIMA. In fact, the only protein proven by complementation to be a functional homologue of NIMA is NIM-1 of Neurospora crassa, another filamentous fungus (Pu et al., 1995) . It is interesting to speculate that the degree of similarity between Nek2 and its closest relatives in other species reflects the degree of structural similarity between the MTOCs in those respective organisms.
Nek2 protein structure
Human Nek2 is a 445 amino acid (48 kDa) protein comprising an N-terminal kinase domain and a Cterminal non-catalytic regulatory domain (Figure 1 ). The kinase domain has all the motifs typical of serine/ threonine protein kinases (Hanks and Hunter, 1995) , and, in vitro, Nek2 phosphorylates substrates on serine and threonine residues usually within a basic context (Fry et al., 1995) . The non-catalytic domain contains two regions predicted to form coiled-coils, one immediately downstream of the kinase domain and one at the extreme C-terminus. The more N-terminal of these coiled-coils bears striking resemblance to a leucine zipper motif having six heptad-spaced leucine residues. Functionally, the Nek2 leucine zipper promotes homodimerization which, in turn, leads to trans-autophosphorylation within the C-terminal region . Very similar results have been obtained with Dictyostelium Nek2 (DdNek2), which has a slightly longer leucine zipper motif in this region (Graf, 2002) . In fact all of the Nek2 related kinases indicated in Table 1 have N-terminal catalytic domains followed by a *50 amino-acid coiled-coil motif. Hence, despite lack of sequence conservation in the C-terminal region, homodimerization and autophosphorylation are likely to be common properties to all these kinases.
Nek2 is expressed in both human and Xenopus, and most likely other vertebrates, as two alternative splice Hanks and Hunter (1995 Ye et al. (1996) , and that Fin1p is involved in nuclear envelope integrity e in Krien et al. (2002) . For references to other proposed functions of Nek2 kinase family members see text Nek2 centrosome kinase AM Fry variants, termed Nek2A and Nek2B (Hames and Fry, 2002; Uto et al., 1999) . The human Nek2A mRNA is encoded on eight exons with the initiator methionine in exon 1 and the termination codon in exon 8. Within intron 7 is an alternative polyadenylation signal which, if preferentially used, would remove exon 8. Hence, Nek2B diverges in sequence from Nek2A at the end of exon 7 and indeed it terminates soon after the splice site (Figure 1 ). Nek2B therefore retains the full catalytic domain and leucine zipper dimerization domain but lacks the second coiled-coil motif and is overall a shorter protein of 389 amino acids (44 kDa).
Both splice variants appear to be ubiquitously expressed, although at low abundance, in cultured adult cells with Nek2A generally the more prominent (Fry et al., 1998a . However, using Xenopus as a model system for early development, only Nek2B is detected in oocytes, eggs and early stages of embryogenesis, with Nek2A first appearing after the gastrulaneurula transition (Uto et al., 1999) . In adult tissues, Nek2 is most abundant in the testis both in Xenopus and mammals and in situ hybridization indicates that Nek2 expression peaks during the meiotic stages of spermatogenesis (Arama et al., 1998; Rhee and Wolgemuth, 1997; Tanaka et al., 1997; Uto et al., 1999) . A possible meiotic role is not restricted to male germ cells as Nek2 is also found in meiotically active oocytes. It is highly unlikely though that Nek2 functions solely in meiosis, as expression is clearly detected in mitotically dividing cells of embryos and adult gonads, as well as cultured cells.
Nek2: a centrosome kinase
Immunofluorescence analysis with cultured cells and anti-Nek2 antibodies first raised the possibility that Nek2 might be a centrosomal protein. Proof that Nek2 is a bona fide component of the vertebrate centrosome has come through demonstrating enrichment of Nek2 protein in isolated centrosome preparations, localization of ectopically-expressed Nek2 constructs to the centrosome in fixed and living cells, detection of centrosomes in mouse testes sections by immunohistochemistry, and recruitment of Nek2 to the zygotic centrosome in Xenopus egg extracts (Fry et al., 1998a (Fry et al., , 2000b Fry and Faragher, 2001; Tanaka et al., 1997; Uto and Sagata, 2000) . Both Nek2 splice variants are present at the centrosome as indicated by localization of recombinant Nek2A and Nek2B in cells and recruitment of both splice variants in egg extracts (Hames and Fry, 2002 ; C Twomey and AM Fry, unpublished results). Nek2 is detected at the centrosome throughout the cell cycle, although the signal at mitotic spindle poles is generally weaker than at interphase centrosomes (Fry et al., 1998a) . This makes sense as Nek2A is destroyed in mitosis (see below), leaving only Nek2B to be found at the spindle poles. In non-vertebrates, DdNek2 localizes to the centrosome corona throughout the cell cycle, while both NIMA and Fin1p have been detected at the SPB albeit only around the time of mitosis (De Souza et al., 2000; Graf, 2002; Krien et al., 2002) . Centrosomal localization of human and Dictyostelium Nek2 is not dependent upon the continued presence of MTs (Fry et al., 1998a; Graf, 2002) , although this does not rule out a contribution from MT-based motors in delivering Nek2 to the centrosome, as has been shown for other centrosomal components such as pericentrin (Zimmerman and Doxsey, 2000) . Preliminary attempts to define the precise localization of Nek2 within the human centrosome by immunoelectron microscopy suggest a preferential localization to the proximal ends of both centrioles (Fry et al., 1998b) . However, more convincing data using different fixation protocols would help to confirm this observation.
Like other proteins that have been found at the centrosome, Nek2 is not exclusively centrosomal and estimates suggest that in asynchronous cells up to 90% of the total pool of cellular Nek2 may not be at the (Fry et al., 1998a) . One presumes that the centrosomal structure has a limited capacity for Nek2 protein and that the non-centrosomal material might simply be in dynamic equilibrium with that at the centrosome. However, another interpretation is that Nek2 has functions unrelated to the centrosome. In this respect, it is curious that when Nek2 is overexpressed, the non-centrosomal pool of protein is found exclusively in the cytoplasm of some cells and the nucleus of others (Fry et al., 1998a ). This appears to be a function of the cell cycle in that the noncentrosomal pool is cytoplasmic in G1 and nuclear in S and G2 (Fry, unpublished data) . Indeed, endogenous Nek2 has been reported in a punctate pattern in the nuclei of cultured cells and mouse germ cells, as well as on both meiotic and mitotic condensed chromosomes Rhee and Wolgemuth, 1997) .
Cell cycle regulated expression of Nek2
Western blot analysis of adult synchronized cells demonstrates that, like NIMA, human Nek2 is a cell cycle-regulated protein kinase (Fry et al., 1995; Hames and Fry, 2002; Schultz et al., 1994) . NIMA expression increases throughout the Aspergillus cell cycle to peak in mitosis . However, the regulation of Nek2 expression is more complex. In G1 phase, both Nek2 splice variants are almost undetectable. However, at the G1/S transition, there is a clear 3 -4-fold increase in expression of both splice variants which then remain at this increased level throughout S and G2. At the onset of mitosis, Nek2A undergoes a rapid disappearance whereas Nek2B continues to be present at about the same level as in G2. During the rest of mitosis Nek2A remains absent, while Nek2B only begins to decline upon re-entry into the next G1 phase.
As antibodies specific for each splice variant are not yet available, it has only been possible to measure total Nek2 activity by immunoprecipitation. Based on in vitro kinase assays with the control substrate b-casein, the activity of Nek2 across the cell cycle appears to reflect the cumulative abundance of the two splice variants. In other words Nek2 activity is low in G1, increases in S and G2 and decreases upon entry into mitosis (Fry et al., 1995) . For reasons explained below, it is possible that post-translational modifications lead to a further transient increase of Nek2 activity in late G2 before the decrease in mitosis. However, this may be so short-lived that only the most careful time-course activity measurements will pick it up.
The cell cycle-regulated expression of Nek2 is most likely regulated by both transcriptional and posttranscriptional mechanisms. Global gene expression studies on serum-stimulated human fibroblasts indicate that Nek2 mRNA levels are highest in S and G2 (Iyer et al., 1999; Ren et al., 2002) . This could result from being either stimulated in S and G2, or repressed in G1. Support for the second of these two hypotheses comes from the detection of E2F4 at the Nek2 promoter in quiescent WI-38 cells (Ren et al., 2002) . E2F4, a member of the E2F transcription factor family, represses transcription of genes in G0 and G1 through recruitment of the Rb-family members p107 and p130 (Takahashi et al., 2000) . These inhibit formation of active transcription complexes by recruiting histone deacetylases which suppress chromatin remodelling. Intriguingly, in p107 7/7 p130 7/7 mouse embryo fibroblasts, the level of Nek2 mRNA is significantly increased even in the absence of serum suggesting that tumours lacking p107 or p130 are likely to have substantially elevated levels of the Nek2 kinase (Ren et al., 2002) .
The sudden loss of Nek2A upon mitotic entry results from degradation by the ATPase-dependent 26S proteasome (Hames et al., 2001) . Proteasomal targeting follows the ubiquitylation of Nek2A by the APC/C (anaphase promoting complex/cyclosome) E3 ubiquitin ligase. It is worth noting that NIMA is also destroyed via APC/C-mediated ubiquitylation during mitosis of Aspergillus cells (Ye et al., 1998) . Two destruction motifs have been identified in the C-terminus of Nek2A downstream of the splice site (Figure 1 ). An extended cyclin A-like D-box which allows recognition by the APC/C Cdc20 protein complex in early mitosis and a KEN box that is recognized by APC Cdh1 in late mitosis and G1 (Hames et al., 2001; Pfleger and Kirschner, 2000) . The very low levels of Nek2A in G1 are thus a combination of both repressed transcription and upregulated protein turnover. The destruction of Nek2A, and cyclin A, from prophase onwards raises intriguing questions about APC/C substrate recognition, as the destruction of other APC/C substrates, such as cyclin B and securin, is inhibited at this stage by the mitotic spindle checkpoint (Shah and Cleveland, 2000) . One possible explanation is that the extended Dbox present in Nek2A and cyclin A allows interaction with a form of the APC/C that is insensitive to the spindle checkpoint protein Mad2. Further study of Nek2A destruction is worthwhile and likely to yield important new insights on how mitotic degradation pathways are controlled.
Substrates and regulators of the Nek2 kinase
So far, three proteins have been shown to be likely in vivo substrates of the Nek2 kinase: C-Nap1, protein phosphatase 1 (PP1) and Nek2 itself. C-Nap1 (centrosomal Nek2-associated protein 1) was identified through interaction with Nek2 in a yeast two-hybrid screen (Fry et al., 1998b) and, independently, as the antigen for a centrosome-reactive autoimmune serum (where it was called Cep250; Mack et al., 1998) . CNap1 is a low abundance, large (281 kDa), mostly coiled-coil protein with no other discernable features. It can interact with and be phosphorylated by Nek2 at both its N-and C-terminal non-coiled-coil regions, although specific phosphorylation sites have not yet been identified (RS Hames and AM Fry, unpublished results; Fry et al., 1998b; Mayor et al., 2000) . High quality immunoelectron microscopy has been performed with several anti-C-Nap1 antibodies on cells that were either untreated or transiently transfected with C-Nap1 constructs (Fry et al., 1998b; Mayor et al., 2000) . The clear picture is of a protein with a highly restricted localization to the proximal ends of both mother and daughter centrioles. There is no staining of pro-centrioles. Reassuringly, this puts CNap1 at precisely the same place within the centrosome as Nek2. Furthermore, like Nek2, its abundance at the centrosome dramatically decreases at the onset to mitosis, although it is not yet clear whether this is a result of degradation or, more simply, displacement. Disruption of C-Nap1 through antibody microinjection (Mayor et al., 2000) has similar consequences to overexpression of Nek2 (Fry et al., 1998a) supporting a functional interaction between these two proteins in regulating centrosome cohesion (see below).
On a number of occasions, Nek2 has been isolated in yeast two-hybrid interactions screens. However, so far, only one of these studies has convincingly shown Nek2 to be a bona fide interacting partner of the protein of interest, and that is with the catalytic subunit of protein phosphatase 1 (PP1c) (Helps et al., 2000) . The Cterminal domain of Nek2A contains a canonical PP1c binding motif (KVHF) commonly found in PP1 regulatory subunits (Cohen, 2002) . Mutation of this motif, which lies after the splice site and so is not present in Nek2B, causes the interaction between Nek2A and PP1 to be lost. Importantly, Nek2 can phosphorylate PP1c, while PP1c can dephosphorylate both Nek2 and C-Nap1 following their phosphorylation by Nek2. Several isoforms of PP1c exist and, of these, it is the PP1a isoform that localizes, in part, at the centrosome consistent with it being in the appropriate place for interaction with Nek2 and C-Nap1 (Andreassen et al., 1998) . Taken together, these data suggest a model in which Nek2, C-Nap1 and PP1 exist in cells as a ternary complex with Nek2 and PP1 antagonistically modulating the phosphorylation state of both Nek2 itself and CNap1 (Figure 2) . If, as is thought, PP1 is inactivated by phosphorylation at the onset of mitosis (Dohadwala et al., 1994; Kwon et al., 1997) , prior to the APC/C mediated destruction of Nek2A, a substantial increase in the level of Nek2A and C-Nap1 phosphorylation should occur. Furthermore, as Nek2 autophosphorylation increases its activity Helps et al., 2000) , the overall effect would be a dramatic spike of CNap1 phosphorylation at the G2/M transition.
A two-hybrid interaction has also been reported between Nek2 and HEC, a protein so named as it is highly expressed in cancer (Chen et al., 1997b) . HEC, a 76 kDa cell cycle regulated protein, associates with mitotic centromeres and microinjection of inhibitory antibodies causes mitotic defects including disordered sister chromatid alignment and multipolar spindles (Chen et al., 1997a) . These phenotypes are suggestive of kinetochore or spindle checkpoint functions. However, HEC also interacts with subunits of the 26S proteasome via a long, C-terminal leucine heptad repeat domain and ectopic expression of HEC interferes with the mitotic destruction of cyclins. Nek2 was isolated through interaction with the HEC coiled coil domain raising the possibility that interaction may be via the Nek2 leucine zipper. It is intriguing that HEC appears to be involved in both mitotic progression and proteasomal activity, but at the moment no other data has been presented to support a physiological interaction between Nek2 and HEC and any possible functional relationship remains entirely speculative.
Unravelling Nek2 function

Centrosome separation
The first attempt to address Nek2 function came through overexpressing wild-type and catalyticallyinactive versions of Nek2 in cultured cells (Fry et al., 1998a) . Transfection of active, but not inactive Nek2, led to the rapid appearance of split centrosomes in almost 50% of transfected cells. In other words, when observed with antibodies against unrelated centrosomal markers, the two closely positioned dots, typically representative of interphase centrosomes, became separated by more than 2 mm (Figure 3 ). This was reminiscent of the separation of centrosomes that normally occurs at the G2/M transition. However, these cells showed no other signs of mitotic onset and there was no recruitment of the kinesin motor Eg5 to the separated centrosomes, as there is when normal mitotic spindle formation begins. The splitting induced by active Nek2 never led to the appearance of four dots implying that it represented the separation of mother and daughter centrioles, and not pro-centrioles from parental centrioles. Splitting of centrioles was also detected in response to microinjection of anti-C-Nap1 antibodies implicating C-Nap1 as a target for Nek2 in this process (Mayor et al., 2000) .
The reason why centrosomes are closely apposed in interphase cells is still a subject of conjecture. One argument states that the forces exerted by centrosomally anchored microtubules on the cell cortex push the two centrosomes together in the centre of the cell (Jean et al., 1999) . This may be true for some cell types, but cannot by itself be the explanation in all cells. For a start, centrosomes isolated from leukaemic cells at 48C and in the presence of nocodazole (both treatments that lead to microtubule depolymerization) appear under the microscope as paired dots. There would seem to be no other explanation for this than the presence of material connecting the two centrosomes. Electron dense material between the proximal ends of the two centrioles has been observed under certain conditions, but it is not particularly structured (Paintrand et al., 1992) . Recent studies in live cells support the existence of an 'inter-centriolar linkage', as mother and daughter centriole exhibit correlated movements as if held together by a flexible spring (Piel et al., 2000) .
The subcellular localization of Nek2 and C-Nap1 on the proximal ends of centrioles is certainly consistent with them playing some role in regulating a connecting structure (Figure 2 ). C-Nap1, a large structural protein, may act as an anchor for the linkage during interphase, when its phosphorylation by Nek2 is counteracted by the action of PP1. However, inactivation, or perhaps displacement, of PP1 in late G2 would allow the phosphorylation of C-Nap1 to increase, causing it to be released from the centrosome with the consequent break up of the linkage (Mayor et al., 1999) . This model would explain why both overexpression of active Nek2 kinase and injection of antibodies against CNap1 cause centriole splitting in interphase.
A more detailed study of centrosome cohesion has revealed that Nek2 is not the only kinase capable of stimulating splitting. Cdk2, in combination with cyclins A or E, also induces centriole splitting (Meraldi and Figure 2 A model for the inter-centriolar linkage. During interphase of the cell cycle, the mother and daughter centrioles are usually found in close proximity suggesting the existence of an inter-centriolar linkage. In support of this, electron dense material is present between the proximal ends of the two centrioles. However, this linkage must be flexible as the daughter centriole in particular exhibits dynamic movements around the mother centriole (Piel et al., 2000) . C-Nap1 and Nek2 are concentrated at the proximal ends of centrioles and can form a ternary complex with PP1. We have evidence that the N-(N) and C-(C) terminal domains of C-Nap1 can physically interact with both Nek2 and with each other (RS Hames and Fry, unpublished observations). One possibility (A) is that a single C-Nap1 molecule might span the inter-centriolar distance. However, this seems unlikely, as antibodies to the central region of C-Nap1 also stain the proximal ends of the centrioles (Mayor et al., 2000) . The second possibility (B) is that CNap1 may act as an anchor for other, as yet unidentified, components of the linkage Nigg, 2001 ). Other centrosomal kinases, such as Plk-1 or Aurora-A, do not cause splitting arguing for some degree of specificity in this response. Intriguingly, centriole splitting induced by the MT inhibitor nocodazole can be suppressed by expression of catalytically-inactive Nek2, but not Cdk2, while PP1 can suppress the splitting induced by active Nek2 (Figure 3) . These results are all consistent with the PP1 -Nek2 complex being the major regulator of centriole cohesion in cells. However, activation of PKA with a cell-permeable cAMP analogue also causes centriole splitting, perhaps via phosphorylation of the centriolar protein centrin (Lutz et al., 2001) . However, in these experiments, the PP1 inhibitor calyculin A was added making it possible that splitting was caused by PP1 inhibition rather than activation of PKA. Finally, overexpression of the phosphatase Cdc14A has now been reported to induce centrosome splitting (Mailand et al., 2002) . Clearly, regulation of centrosome cohesion is a complex business and, whilst phosphorylation is consistently implicated, we will only begin to understand this process when other components of the inter-centriolar linkage are identified.
Centrosome structure and spindle formation
Evidence from different systems strongly supports another role for Nek2 in assembly and maintenance Figure 3 Experimental consequences of Nek2 disruption in vertebrate systems. Experiments in human and Xenopus systems have led to the hypothesis that Nek2 is functionally involved in both centriole splitting and assembly and maintenance of the centrosome structure. (A) In human cells, overexpression of wild-type Nek2A kinase or injection of C-Nap1 antibodies induces centriole splitting. Co-expression of PP1c with wild-type Nek2A suppresses splitting. Long-term overexpression of wild-type or catalyticallyinactive Nek2A leads to dispersal of pericentriolar material. It is not known whether centrioles remain intact under these conditions or, with inactive Nek2, whether the centrioles are still linked. (B) Introduction of demembranated Xenopus sperm into cytoplasmic extracts of Xenopus eggs leads to assembly of a functional centrosome at the site of the basal body. However, if Nek2B is depleted from the extracts, centrosome assembly is delayed. (C) Microinjection of Nek2 antibodies or constructs expressing a catalyticallydead Nek2B kinase into Xenopus embryos causes fragmentation or dispersal of centrosomes with concomitant disruption of spindle formation of the centrosome structure. Disruption of Nek2 can therefore indirectly lead to defects in both MT organization and spindle formation. Again the first sign of this came from overexpression studies in human cells, where it was found that by 48 h after Nek2 transfection centrosomes could hardly be detected using antibodies against a variety of centrosomal antigens (Fry et al., 1998a) . Moreover, a focused centre of MT nucleation has also disappeared. This phenotype, in contrast to centriole splitting, was not dependent upon kinase activity as it resulted from overexpression of either active or inactive Nek2 ( Figure  3) . The most straightforward interpretation of this result is that excess Nek2, that can no longer be accommodated at the centrosome, titrates other proteins with which it can interact out of the centrosome causing its collapse.
More direct support for a role in structural organization of the centrosome has come from studies performed in Xenopus embryos and egg extracts where only Nek2B is present (Figure 3 ; Fry et al., 2000b; Uto and Sagata, 2000) . Microinjection of anti-Nek2 antibodies or constructs expressing catalytically-inactive Nek2 into embryos causes centrosome fragmentation which, in turn, leads to aberrant mitotic spindle formation and cleavage failure (Uto and Sagata, 2000) . Introduction of Nek2 antibodies or constructs into oocytes had no such effect on meiotic spindle formation and, as female meiotic spindles are acentrosomal, this implies that the function of Nek2B with respect to spindle formation is limited to the centrosome. When Nek2B was removed from cytoplasmic egg extracts by immunodepletion, the rate of functional centrosome formation from sperm basal bodies was retarded (Fry et al., 2000b) . Hence, as well as being critical for maintaining the integrity of centrosomes, Nek2B is also important in their assembly. It could be that the Nek2B isoform is primarily involved in assembly and maintenance of centrosomes in adult, as well as embryonic, cells, whilst Nek2A is more important in regulating the control of centriolar cohesion. If this were true, one might expect centriolar cohesion not to be regulated in early embryos. Indeed, intercentriolar linkages may only form later in development, when Nek2A begins to be expressed. It would be revealing to know, (a) whether centrosomes isolated from embryonic cells are usually paired or not, and (b) at what time in development C-Nap1 is first expressed.
Dictyostelium Nek2 resembles Nek2B more than Nek2A as it lacks the PP1c binding site and C-terminal destruction motifs. Strikingly, overexpression of DdNek2 leads to generation of multiple MTOCs in cells, also pointing to a role in centrosome assembly or maintenance (Graf, 2002) . The Dictyostelium centrosome is a layered box structure that lacks centrioles and may represent an intermediate stage between centrosomes and SPBs (Graf et al., 2000) . Like the fission yeast SPB, it is associated with the outside of the nucleus during interphase, but drops into the nuclear envelope at mitosis to allow spindle formation.
The supernumerary MTOCs that result from DdNek2 overexpression do not seem to be the consequence of centrosome dispersal as the bona fide centrosome is still present and the ectopic MTOCs are a similar size to centrosomes and contain many of the normal centrosome markers. So either, the overexpressed DdNek2 has the capacity to stimulate assembly of additional MTOCs, or it triggers additional rounds of centrosome duplication in the absence of cell division. Although a role for Nek2 in centrosome duplication cannot be ruled out, the fact that multiple MTOCs are induced with both active and inactive DdNek2 argues against DdNek2 kinase activity being a specific promoter or inhibitor of duplication.
The question over whether an SPB function is conserved in Nek2-related kinases in Aspergillus or yeast is an interesting one. Temperature-sensitive mutants of NIMA arrest in G2 making it difficult to know whether NIMA has a specific role in spindle formation. However, in these mutants, cyclin B also fails to correctly localize at the SPB implying that NIMA may have a role in assembling cyclin B at the SPB (Wu et al., 1998) . In S. pombe, deletion of Fin1p does not cause a strong G2 arrest allowing cells to progress into mitosis. However, these cells are hypersensitive to microtubule poisons, synthetically lethal with mutants in spindle components and sensitive to the integrity of the spindle checkpoint (Krien et al., 2002) . Temperature-sensitive fin1 mutants have also been isolated and exhibit defects in spindle formation apparently due to the failure of one of the two SPBs to nucleate MTs (Grallert and Hagan, 2002) . Excitingly, Fin1p may also be required for recruitment of Polo kinase to the SPB at the G2/M transition, as elevated Fin1p causes Polo to be detected at interphase SPBs where it is normally not present. Moreover, fin 1 mutation prevents the premature recruitment of Polo to interphase SPBs that occurs when another SPB component, Cut12, is mutated. These results imply that spindle formation is retarded or abnormal in fin1 mutants due to defects in SPB organization, although these errors only become lethal when combined with other factors that interfere with or monitor spindle formation.
G2/M progression
A major question that has dogged the field is whether a 'NIMA' homologue required for mitotic entry exists in organisms beyond filamentous fungi. Initial optimism that the G2/M function of NIMA may be universally conserved, in a similar manner to the absolute requirement for Cdc2 activity, was dampened by the failure to isolate NIMA homologues in yeast screens for cell cycle mutants. With completion of the budding yeast genome in 1997, it became clear that the closest homologue to NIMA in this organism is KIN3, deletion of which does not prevent cell growth (Barton et al., 1992; Jones and Rosamond, 1990; Schweitzer and Philippsen, 1992) . Likewise, in fission yeast, whose sequence is also now complete, only the non-essential Fin1p bears significant similarity to NIMA (Krien et al., 1998) . However, as discussed already, Fin1p does become essential when the spindle checkpoint is missing. This was interpreted above as highlighting a role for Fin1p in SPB organization and spindle formation. On the other hand, the genetic interaction of Fin1 with mutants that alter G2/M control strongly suggests that Fin1p also cooperates directly with the Cdc2 and Polo kinases in mitotic commitment (Grallert and Hagan, 2002) . In an attractive model, Fin1, and Cut12, would regulate recruitment to the SPB of Polo, which in turn would promote the activation of Cdc2 via stimulation of the Cdc25 phosphatase and inhibition of the Wee1 kinase. Hence, the recruitment of Polo to the SPB by Fin1p may be an important step not only for ensuring the correct formation of a bipolar spindle, but also for promoting mitotic entry. Clearly, these two events are intricately linked and spindle defects could then arise due to incomplete commitment to mitosis. More work is needed to distinguish whether they are truly independent activities of Fin1p.
The first tantalizing evidence that mammalian Nek2 might yet have a role in the G2/M transition has been obtained in cell lines expressing catalytically-inactive Nek2 from a tetracycline-inducible promoter (Faragher and Fry, unpublished observations). Treatment of these cells with tetracycline over several days leads to a dramatic shift in the cell cycle distribution with an obvious rise in the fraction of G2/M cells. Despite also having centrosome and spindle defects, there does not seem to be a significant increase in mitotic index suggesting that the cell cycle shift is representative of a delay in G2. Clearly, this is only a first observation but it means that a function for Nek2 in mitotic commitment in human cells remains an exciting possibility.
Chromatin condensation
Overexpression of the NIMA kinase in Aspergillus led to a plethora of phenotypes typical of a premature mitotic onset (Osmani et al., 1988) . These included the induction and maintenance of chromatin condensation, as well as the disassembly of an interphase MT array and formation of a mitotic spindle. Subsequent overexpression of Aspergillus NIMA in fission yeast, Xenopus oocytes and cultured human cells also led to the consistent appearance of condensed chromatin (Lu and Hunter, 1995; O'Connell et al., 1994) . These data were used to support the idea that NIMA-like pathways were conserved throughout all eukaryotes. However, how NIMA might stimulate chromatin condensation has remained rather obscure. The mitotic phosphorylation of serine 10 of histone H3 has more recently been shown to be dependent upon NIMA kinase activity (De Souza et al., 2000) . However, it seems unlikely that NIMA itself is the kinase for Ser-10 of H3 as there is now convincing evidence in many systems that this job is done by the Aurora-B kinase (Adams et al., 2001 ). Chromatin condensation is also induced by overexpression of Fin1p in fission yeast. However, this condensation is highly unusual as it is not accompanied by histone H3 phosphorylation and can occur in the absence of topoisomerase II or condensin subunits (Krien et al., 2002) . This has raised some doubt over whether the chromatin condensation induced by Fin1p, or indeed NIMA in different organisms, is not in fact non-physiological consequence of protein overexpression.
The notion that vertebrate Nek2 is involved in chromatin condensation is somewhat controversial. As mentioned earlier, some localization studies have found a fraction of endogenous Nek2 associated with chromatin, particularly in cells undergoing meiosis (Fujioka et al., 2000; Kim et al., 2002; Rhee and Wolgemuth, 1997) . However, other studies have failed to detect such a localization (e.g. Tanaka et al., 1997) . So far, functional assays also do not support a role for Nek2 in chromatin condensation as Xenopus Nek2B is not recruited to condensed sperm chromatin in mitotic egg extracts, and immunodepletion of Nek2 does not interfere with either condensation or decondensation of chromatin in vitro (Fry et al., 2000b) . Moreover, in contrast to the effect of overexpressing NIMA, expression of Nek2 or Fin1p in human cells does not induce chromatin condensation (Fry et al., 1998a; Krien et al., 2002) . Interestingly, there is a correlation between activation of Nek2 and the experimental induction of condensation in okadaic acid-treated meiotic spermatocytes (Rhee and Wolgemuth, 1997) . This induction of condensation requires the MAPK pathway and the MAPK effector p90
Rsk2 and inhibiting MAPK in the presence of okadaic acid prevents not only chromatin condensation, but also activation of Nek2 (Di Agostino et al., 2002) . Nek2 can be directly phosphorylated and activated in vitro by p90
Rsk2 , but whether Nek2 is the genuine target of the MAPK pathway that leads to chromatin condensation in vivo is not known. Hence, a role for Nek2 in chromatin condensation in certain cell types, or perhaps specifically during meiotic cell division, is possible but at the present time remains to be proven.
Future perspectives
From humans to yeast, Nek2-related kinases have been firmly established as centrosome/SPB components. Furthermore, considerable progress has been made in uncovering the mechanisms that regulate Nek2 expression and activity. However, a great deal still remains to be learnt, particularly about the function(s) of Nek2 at the centrosome and in cell cycle progression. To make progress in this direction, we first need to identify more substrates of Nek2, as it is highly unlikely that C-Nap1 is the only major target of Nek2 at the centrosome. Even for C-Nap1 we do not know what the consequences of its phosphorylation by Nek2 are and, for this, the sites of phosphorylation must be identified and mutated. Loss of function approaches also need to be performed in mammalian cells through introduction of double-stranded RNAi oligonucleotides, antisense constructs or inhibitory antibodies. Hopefully, these methodologies will help to throw more light on whether Nek2 has important roles in mitotic commitment and chromatin condensation, as well as in the centrosome cycle. Concerning Nek2 regulation, we still need to demonstrate the purpose of its association with PP1 in vivo: is it to keep Nek2 substrates dephosphorylated at certain times in the cell cycle as proposed, or could it be to modulate Nek2 structure thereby influencing its interaction with other proteins? And as Nek2B lacks the PP1 binding site, does this mean that it is constitutively active once expressed? Another important question is why Nek2A destruction is necessary in early mitosis, when Nek2B remains present. Finally, it is now imperative to systematically investigate whether Nek2 is altered in any way in cancer. The fact that it is a target of p107/ p130-regulated transcription strongly suggests that it will be upregulated in those cancers lacking these tumour suppressor genes. The first report that Nek2 expression is increased in certain tumour cells has come from microarray studies of Ewing tumour-derived cell lines (Wai et al., 2002) . A clear link between Nek2 kinase activity and tumour cell status would certainly serve to further intensify interest in this novel centrosome regulator.
Note added in proof FA2, a NIMA-related kinase from Chlamydomonas reinhardtii, has recently been implicated in both centrioleassociated microtubule severing and G2/M progression (Mahjoub et al., 2002) . Hence, conserved functions for kinases related to Nek2 in MTOC regulation and cell cycle progression may also extend to certain plant species.
